The Rosen Law Firm, a global investor rights law firm, announced a class action lawsuit against RxSight, Inc. (NASDAQ: RXST). The firm is representing investors who purchased RxSight securities during a specified period, from November 7, 2024, to July 8, 2025.
The lawsuit alleges that RxSight made false and misleading statements to investors. These statements allegedly misrepresented the company’s sales and utilization, overstated demand for its products, and ultimately failed to meet its financial guidance for fiscal year 2025.
According to the Rosen Law Firm, these inaccuracies caused investors to suffer financial losses when the truth about RxSight‘s performance emerged. The firm contends that the company’s positive statements regarding its business and prospects were not supported by facts.
The Rosen Law Firm is urging investors who purchased RxSight securities during the specified period to contact them. The firm is offering its services on a contingency fee basis, meaning clients won’t incur any out-of-pocket costs. A lead plaintiff must be selected by September 22, 2025.
The Rosen Law Firm highlighted its extensive experience in securities class action lawsuits. The firm stated its record of success includes securing significant settlements for investors, including the largest-ever settlement against a Chinese company at the time. They also mentioned their top rankings in securities class action settlements.
The firm emphasized the importance of choosing qualified legal counsel with a proven track record. They pointed out that many firms issuing similar notices lack the experience, resources, and recognition of established firms like Rosen Law Firm. They encouraged investors to carefully consider their choice of legal representation.
While a class has not yet been certified, investors who believe they have been harmed by RxSight‘s alleged misrepresentations are encouraged to contact the Rosen Law Firm to learn more about their rights. The firm emphasized that participation in the lawsuit isn’t contingent on becoming a lead plaintiff. Investors can choose to remain absent class members.
The Rosen Law Firm provided contact information for interested investors, including a phone number and email address. They further clarified that prior results do not guarantee similar outcomes in future cases. The firm concluded its announcement by reiterating the deadline for selecting a lead plaintiff.
Related
